Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


21.04.2025

1 3 Biotech
1 Abdom Radiol (NY)
2 Am J Cancer Res
2 Am J Surg Pathol
1 Am J Transl Res
1 Arch Biochem Biophys
1 Biochem Biophys Rep
1 Biomol Biomed
2 BMC Cancer
1 BMC Health Serv Res
1 BMC Womens Health
1 BMJ Case Rep
1 Can J Infect Dis Med Microbiol
2 Cancer Cell Int
1 Cancers (Basel)
1 China CDC Wkly
1 Clin Radiol
1 Cochrane Database Syst Rev
1 Comput Inform Nurs
1 Crit Rev Oncol Hematol
1 Front Immunol
2 Front Oncol
1 Front Public Health
1 Genome Res
2 Gynecol Oncol
1 Health Sci Rep
1 Healthcare (Basel)
1 Hum Cell
2 Infect Agent Cancer
1 Int J Environ Res Public Health
1 Int J Gynaecol Obstet
12 Int J Gynecol Cancer
2 Int J Mol Sci
1 Int Wound J
1 J Gynecol Oncol
1 J Imaging Inform Med
1 J Infect Dis
1 J Int Med Res
1 J Investig Med
1 J Low Genit Tract Dis
1 J Med Virol
1 J Pediatr Adolesc Gynecol
1 J Pharm Biomed Anal
1 J Virol Methods
1 JNCI Cancer Spectr
1 Mamm Genome
1 Medicine (Baltimore)
1 Nat Commun
1 Obstet Gynecol
3 Oncol Lett
1 Orv Hetil
2 PLoS One
1 Probiotics Antimicrob Proteins
1 Quant Imaging Med Surg
1 Rev Bras Ginecol Obstet
1 Sci Prog
4 Sci Rep
1 Semin Reprod Med
1 Sex Transm Infect
1 Transl Cancer Res
1 Transl Oncol
1 West Afr J Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    3 Biotech

  1. KRISHNAMOORTHY S, Vasudevan S, Muruganantham B, Muthusami S, et al
    Epinephrine augments the phosphorylation of EGFR and promote the DNA synthesis and migration of cervical cancer cells.
    3 Biotech. 2025;15:125.
    PubMed         Abstract available


    Abdom Radiol (NY)

  2. MA X, Zhang L, Lu J, Xu P, et al
    Development and validation of ADC-based nomogram model for predicting the prognostic factors in preoperative clinical early-stage cervical cancer patients.
    Abdom Radiol (NY). 2025 Apr 15. doi: 10.1007/s00261-025-04944.
    PubMed         Abstract available


    Am J Cancer Res

  3. LI N, Peng E, Liu F
    Prediction of lymph node metastasis in cervical cancer patients using AdaBoost machine learning model: analysis of risk factors.
    Am J Cancer Res. 2025;15:1158-1173.
    PubMed         Abstract available

  4. HOU Y, Zhang L, Wang H, Wang W, et al
    Development and validation of a risk prediction model for lymph node metastasis in stage IA2-IIA1 cervical cancer based on laboratory parameters.
    Am J Cancer Res. 2025;15:1081-1095.
    PubMed         Abstract available


    Am J Surg Pathol

  5. WILLIAMS GA 2ND, Wu AA, Eugene HC, Tsai YC, et al
    Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva.
    Am J Surg Pathol. 2025 Jan 31. doi: 10.1097/PAS.0000000000002367.
    PubMed         Abstract available

  6. KAMIJO K, Miyamoto T, Oshima S, Asaka S, et al
    Extensive Pathologic Invasion and Prognostic Implication of Gastric-Type Cervical Adenocarcinoma: A Comparative Analysis With Human Papillomavirus-Associated Adenocarcinoma.
    Am J Surg Pathol. 2025;49:471-480.
    PubMed         Abstract available


    Am J Transl Res

  7. LUO M, Liu Y, Lv Y
    Laparoscopic radical hysterectomy and pelvic lymph node dissection for early cervical cancer effectively improves surgical efficacy.
    Am J Transl Res. 2025;17:2103-2111.
    PubMed         Abstract available


    Arch Biochem Biophys

  8. MANJILI DA, Babaei FN, Younesirad T, Ghadir S, et al
    Dysregulated circular RNA and long non-coding RNA-Mediated regulatory competing endogenous RNA networks (ceRNETs) in ovarian and cervical cancers: A non-coding RNA-Mediated mechanism of chemotherapeutic resistance with new emerging clinical capacities
    Arch Biochem Biophys. 2025;768:110389.
    PubMed         Abstract available


    Biochem Biophys Rep

  9. REDDY R, Gaiwak V, Goda JS, Teni T, et al
    'Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis.
    Biochem Biophys Rep. 2025;42:101987.
    PubMed         Abstract available


    Biomol Biomed

  10. WANG Y, Cui W, Chu DM
    Role of Fascin-1 in cervical cancer metastasis via Wnt/beta-catenin pathway activation.
    Biomol Biomed. 2025 Mar 14. doi: 10.17305/bb.2025.12114.
    PubMed         Abstract available


    BMC Cancer

  11. XAVIER SP, Galvao ND, das Neves MAB, da Silva KM, et al
    Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil.
    BMC Cancer. 2025;25:684.
    PubMed         Abstract available

  12. ZHANG C, Chen L
    6-Methoxyflavone inhibits glycolytic energy metabolism in HeLa cells.
    BMC Cancer. 2025;25:719.
    PubMed         Abstract available


    BMC Health Serv Res

  13. BLUM AC, Tessema R, Nussbaum L, Hidalgo C, et al
    "The problem is not detection, it is treatment": exploring why women needing pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.
    BMC Health Serv Res. 2025;25:544.
    PubMed         Abstract available


    BMC Womens Health

  14. ZHANG S, Wang J, Zhu L
    The overtreatment rate, medical cost and psychological affection of see-and-treat versus three-step approaches in the treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis.
    BMC Womens Health. 2025;25:179.
    PubMed         Abstract available


    BMJ Case Rep

  15. VALENTIN ME, Abdelal Q, Isern S, Ashby T, et al
    Rapidly progressive pneumonitis days after receiving tisotumab vedotin: a new antibody-drug conjugate.
    BMJ Case Rep. 2025;18:e264150.
    PubMed         Abstract available


    Can J Infect Dis Med Microbiol

  16. HUERTA-PADILLA V, Marrero-Rodriguez D, Taniguchi-Ponciano K, Lopez AE, et al
    Thymopoietin-alpha, -beta, and -gamma Isoforms Increased Expression in Cervical Cancer Cells.
    Can J Infect Dis Med Microbiol. 2025;2025:1668482.
    PubMed         Abstract available


    Cancer Cell Int

  17. YUAN L, Wen B, Li X, Lei H, et al
    A Chinese prospective cohort research developed and validated a risk prediction model for patients with cervical cancer.
    Cancer Cell Int. 2025;25:142.
    PubMed         Abstract available

  18. TAGHIZADIEH M, Kalantari M, Bakhshali R, Kobravi S, et al
    To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death.
    Cancer Cell Int. 2025;25:153.
    PubMed         Abstract available


    Cancers (Basel)

  19. DEAN A, Eldawy N, Mendonca J, Lobaina D, et al
    HPV-Related Knowledge and Impact of Patient-Provider Communication on HPV-Associated Cervical Cancer Awareness and Pap Smear Completion in US Women Aged 21-65 Years.
    Cancers (Basel). 2025;17:1188.
    PubMed         Abstract available


    China CDC Wkly

  20. ZHANG M, Wang L, Zhang X, Li C, et al
    Cervical Cancer Screening Rates Among Chinese Women - China, 2023-2024.
    China CDC Wkly. 2025;7:321-326.
    PubMed         Abstract available


    Clin Radiol

  21. MALEK M, Moayeri M, Akhavan S, Hasani SS, et al
    Advanced MRI prediction model for anatomical site identification in uterine carcinoma: enhancing diagnostic accuracy.
    Clin Radiol. 2025;84:106852.
    PubMed         Abstract available


    Cochrane Database Syst Rev

  22. COOPER S, Schmidt BM, Jama NA, Ryan J, et al
    Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.
    Cochrane Database Syst Rev. 2025;4:CD013430.
    PubMed         Abstract available


    Comput Inform Nurs

  23. KORKMAZ ASLAN G, Kilinc Isleyen E, Kartal A
    Associations of eHealth Literacy With Cervical Cancer and Human Papillomavirus Awareness Among Women in Turkiye: A Cross-sectional Study.
    Comput Inform Nurs. 2025 Apr 18. doi: 10.1097/CIN.0000000000001314.
    PubMed         Abstract available


    Crit Rev Oncol Hematol

  24. RANASINGHE V, McMillan N
    Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical cancer.
    Crit Rev Oncol Hematol. 2025;211:104721.
    PubMed         Abstract available


    Front Immunol

  25. XIANG Z, Li Z, Chen X, Fu Y, et al
    Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis.
    Front Immunol. 2025;16:1562875.
    PubMed         Abstract available


    Front Oncol

  26. MOHAMMED E, Kaba M, Taye G, Assefa M, et al
    Reasons for not undergoing cervical cancer screening: perspectives from women and health care providers in Addis Ababa: a qualitative study.
    Front Oncol. 2025;15:1456804.
    PubMed         Abstract available

  27. DAI X, Ye X, Ren J, Yang J, et al
    Construction of the preoperative staging prediction model for cervical cancer based on deep learning and MRI: a retrospective study.
    Front Oncol. 2025;15:1557486.
    PubMed         Abstract available


    Front Public Health

  28. JABBARI A, Najafpour Z, Ourang S, Cheraghi M, et al
    Developing and validating key performance indicators for breast, cervical, and colorectal cancer screening programs: a literature review and Delphi survey.
    Front Public Health. 2025;13:1491226.
    PubMed         Abstract available


    Genome Res

  29. PORTER VL, Ng M, O'Neill K, MacLennan S, et al
    Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation.
    Genome Res. 2025;35:653-670.
    PubMed         Abstract available


    Gynecol Oncol

  30. BORCINOVA M, Kohler C, Nemejcova K, Zapardiel I, et al
    Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study.
    Gynecol Oncol. 2025;196:160-167.
    PubMed         Abstract available

  31. VELASQUEZ J, Mohammed-Norgan M, Scheiber A, Chalif J, et al
    Cross-language insights: Comparing Spanish and English-language cervical cancer content on TikTok.
    Gynecol Oncol. 2025;194:131-136.
    PubMed         Abstract available


    Health Sci Rep

  32. BAWUAH A, Wang VQ, Adeleye K, Ameyaw EK, et al
    Mass Media Exposure and Cervical Cancer Screening in Rural Sub-Saharan Africa: A Multi-Country Cross-Sectional Analysis.
    Health Sci Rep. 2025;8:e70663.
    PubMed         Abstract available


    Healthcare (Basel)

  33. YUKSEL GH, Ozaydin AN
    Assessment of Health Beliefs and Motivations for Cervical Cancer Screening.
    Healthcare (Basel). 2025;13:804.
    PubMed         Abstract available


    Hum Cell

  34. LIU X, Ren H, Wang A, Liang Z, et al
    SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1.
    Hum Cell. 2025;38:88.
    PubMed         Abstract available


    Infect Agent Cancer

  35. DE OLIVEIRA CM, Rangeiro R, Osman N, Baker E, et al
    Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique.
    Infect Agent Cancer. 2025;20:24.
    PubMed         Abstract available

  36. ZHOU D, Hou J, Xi J, Li Y, et al
    Cost-benefit analysis of p16(INK4a) immunocytology and liquid-based cytology triage after primary HPV testing for cervical cancer screening in China.
    Infect Agent Cancer. 2025;20:26.
    PubMed         Abstract available


    Int J Environ Res Public Health

  37. ADEGBOYEGA A, Mudd-Martin G, Schoenberg NE, Dignan M, et al
    HPV Self-Sampling Promotion Among African American (AA) and Sub-Saharan African (SAI) Immigrant Women: Adaptation and Usability Testing.
    Int J Environ Res Public Health. 2025;22:317.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  38. SHANG X, Kong L, You Y, Wu H, et al
    Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results.
    Int J Gynaecol Obstet. 2025 Apr 16. doi: 10.1002/ijgo.70167.
    PubMed         Abstract available


    Int J Gynecol Cancer

  39. TESFAI FM, Yongue G, Chandrasekaran D, Francis N, et al
    Methods of surgical quality assurance in cervical and endometrial cancer trials: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2025;35:100018.
    PubMed         Abstract available

  40. SALANI R, McCormack M, Kim YM, Ghamande S, et al
    A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
    Int J Gynecol Cancer. 2024;34:1140-1148.
    PubMed         Abstract available

  41. PAN TL, Pareja R, Chiva L, Rodriguez J, et al
    Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2024;34:1861-1866.
    PubMed         Abstract available

  42. GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al
    Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging.
    Int J Gynecol Cancer. 2024;34:1867-1873.
    PubMed         Abstract available

  43. LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al
    Are we making progress in curing advanced cervical cancer-again?
    Int J Gynecol Cancer. 2024;34:1940-1945.
    PubMed         Abstract available

  44. MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al
    Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial.
    Int J Gynecol Cancer. 2024;34:1691-1697.
    PubMed         Abstract available

  45. CHAMBULE S, Rangeiro R, Batman S, Lathrop E, et al
    Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical excision procedure (LEEP) specimens.
    Int J Gynecol Cancer. 2024;34:1698-1703.
    PubMed         Abstract available

  46. CHEN M, Han L, Wang Y, Chen Y, et al
    Association between Silva pattern-based classification and endocervical adenocarcinoma: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2024;34:1704-1710.
    PubMed         Abstract available

  47. BIZZARRI N, Abu-Rustum NR, Plante M, Ramirez PT, et al
    Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial.
    Int J Gynecol Cancer. 2024;34:1805-1808.
    PubMed         Abstract available

  48. MATSUO K, Shimada M, Matsuzaki S, Machida H, et al
    Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024;34:1349-1358.
    PubMed         Abstract available

  49. GUO XM, Roman LD, Matsuo K
    Considerations for route of hysterectomy in low-risk cervical cancer.
    Int J Gynecol Cancer. 2024;34:1481.
    PubMed        

  50. GAO H, Wu H, Zhang Y, Li X, et al
    Long-term survival in patients with para-aortic metastatic cervical cancer receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a single-center experience.
    Int J Gynecol Cancer. 2024;34:1536-1546.
    PubMed         Abstract available


    Int J Mol Sci

  51. FLORKEMEIER I, Hotze HL, Heyne AL, Hildebrandt J, et al
    Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.
    Int J Mol Sci. 2025;26:2829.
    PubMed         Abstract available

  52. CHEN CC, Wang S, Yang JM, Huang CH, et al
    Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through Combined Inhibition of FAK and PI3K.
    Int J Mol Sci. 2025;26:3040.
    PubMed         Abstract available


    Int Wound J


  53. RETRACTION: A Meta-Analysis Examining the Impact of Open Surgical Therapy versus Minimally Invasive Surgery on Wound Infection in Females With Cervical Cancer.
    Int Wound J. 2025;22:e70573.
    PubMed         Abstract available


    J Gynecol Oncol

  54. WANG Y, Wang M, Zhu L
    The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer patients after surgery.
    J Gynecol Oncol. 2025 Apr 8. doi: 10.3802/jgo.2025.
    PubMed         Abstract available


    J Imaging Inform Med

  55. TIAN M, Qin F, Sun X, Pang H, et al
    A Hybrid Model-Based Clinicopathological Features and Radiomics Based on Conventional MRI for Predicting Lymph Node Metastasis and DFS in Cervical Cancer.
    J Imaging Inform Med. 2025 Apr 18. doi: 10.1007/s10278-024-01371.
    PubMed         Abstract available


    J Infect Dis

  56. GRAY P, Wang J, Nordqvist Kleppe S, Elfstrom KM, et al
    Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence.
    J Infect Dis. 2025;231:e638-e649.
    PubMed         Abstract available


    J Int Med Res

  57. SU L, Xu R, Ren Y, Zhao S, et al
    5-Methylcytosine methylation predicts cervical cancer prognosis, shaping immune cell infiltration.
    J Int Med Res. 2025;53:3000605251328301.
    PubMed         Abstract available


    J Investig Med


  58. Retraction: "Mir-3150B-3P Inhibits the Proliferation and Invasion of Cervical Cancer Cells by Targeting Tnfrsf11A".
    J Investig Med. 2025 Apr 14:10815589251332430. doi: 10.1177/10815589251332430.
    PubMed        


    J Low Genit Tract Dis

  59. EBISCH RMF, Buijssen C, Visser NCM, Siebers AG, et al
    The Risk of Developing Cervical Cancer in the Elderly; Who Benefits From Screening After the Age of 60?
    J Low Genit Tract Dis. 2025 Apr 18. doi: 10.1097/LGT.0000000000000893.
    PubMed         Abstract available


    J Med Virol

  60. WANG Y, Wang Z, Qu W, Chen F, et al
    Patterns of Co-infection of HPV52 With Other HPV Genotypes and Their Risks of Cervical Precancer and Carcinoma.
    J Med Virol. 2025;97:e70312.
    PubMed         Abstract available


    J Pediatr Adolesc Gynecol

  61. MATUSIAK K, Bumbuliene Z
    "Polish mothers and cervical cancer prophylaxis. What do they know and what attitude do they have towards HPV vaccination?".
    J Pediatr Adolesc Gynecol. 2025 Apr 12:S1083-3188(25)00239.
    PubMed         Abstract available


    J Pharm Biomed Anal

  62. ZHU JF, Wang YQ, Yang SM, Wang YL, et al
    Exploring the mechanism of Bruceine D against cervical cancer by network pharmacology and the effect of Bruceine D on the EGFR pathway.
    J Pharm Biomed Anal. 2025;262:116887.
    PubMed         Abstract available


    J Virol Methods

  63. KEUNG MHT, Mehta N, Lynn E, Pineda E, et al
    Clinical validation of the Roche cobas HPV test on the Roche cobas 6800 system for the purpose of cervical screening and qualification as a second-generation comparator test.
    J Virol Methods. 2025;335:115145.
    PubMed         Abstract available


    JNCI Cancer Spectr

  64. KARIM MA, Zhang N, Zhao H, Shih YT, et al
    Trends in Medicare payments within the first year of cervical cancer diagnosis, 2010-2019.
    JNCI Cancer Spectr. 2025 Apr 16:pkaf043. doi: 10.1093.
    PubMed         Abstract available


    Mamm Genome

  65. AGNILA DRL, Jain R, Diaz MJ, Hudlock TR, et al
    TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancer.
    Mamm Genome. 2025 Apr 11. doi: 10.1007/s00335-025-10127.
    PubMed         Abstract available


    Medicine (Baltimore)

  66. FAN Y, Liu S, Zhao J, Fu Y, et al
    Intestinal perforation in recurrent cervical cancer following bevacizumab and pembrolizumab therapy: A case report.
    Medicine (Baltimore). 2025;104:e40473.
    PubMed         Abstract available


    Nat Commun

  67. XUE P, Dang L, Kong LH, Tang HP, et al
    Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection.
    Nat Commun. 2025;16:3506.
    PubMed         Abstract available


    Obstet Gynecol

  68. WANG V, Lykken JM, Tiro JA, Perkins RB, et al
    Guideline-Concordant Surveillance After Treatment for High-Grade Cervical Dysplasia.
    Obstet Gynecol. 2025;145:461-468.
    PubMed         Abstract available


    Oncol Lett

  69. SHEN L, Wen N, Xia M, Zhang Y, et al
    Erratum: [Corrigendum] Calcium efflux from the endoplasmic reticulum regulates cisplatin?induced apoptosis in human cervical cancer HeLa cells.
    Oncol Lett. 2025;29:274.
    PubMed         Abstract available

  70. LIU RC, Ji YM, Huang J, Du YP, et al
    Charged multivesicular body protein 4C promotes the progression of cervical cancer through the HPV E6/miR?543 axis.
    Oncol Lett. 2025;29:275.
    PubMed         Abstract available

  71. HU M, Ji L, Jin L, Shao M, et al
    Minimally invasive surgery for cervical cancer.
    Oncol Lett. 2025;29:281.
    PubMed         Abstract available


    Orv Hetil

  72. DOBROSSY L
    [Calvary of cytology-based cervical screening in Hungary].
    Orv Hetil. 2025;166:578-587.
    PubMed        


    PLoS One

  73. ABATE A, Munshea A, Nibret E, Bezabih B, et al
    Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia.
    PLoS One. 2025;20:e0321076.
    PubMed         Abstract available

  74. WANG G, Jia C, Wang D, Liang L, et al
    Scutellaria Barbata inhibits epithelial-mesenchymal transformation through PI3K/AKT and MDM2 thus inhibiting the proliferation, migration and promoting apoptosis of Cervical Cancer cells.
    PLoS One. 2025;20:e0321556.
    PubMed         Abstract available


    Probiotics Antimicrob Proteins

  75. LI H, Zhou D, Wang W, Aimaier R, et al
    Mycosubtilin Induces G1 Phase Block and Autophagy in Cervical Cancer HeLa Cells.
    Probiotics Antimicrob Proteins. 2025 Apr 17. doi: 10.1007/s12602-025-10534.
    PubMed         Abstract available


    Quant Imaging Med Surg

  76. WU M, Zhang K, Li Y, Yu B, et al
    Endovaginal coil combined with pelvic array coil magnetic resonance imaging for the preoperative staging of cervical cancer.
    Quant Imaging Med Surg. 2025;15:3189-3197.
    PubMed         Abstract available


    Rev Bras Ginecol Obstet

  77. LICHTENFELS M, Almeida Lima Nunes R, Mendoza Lopez RV, Alves da Silva C, et al
    Gastrin-releasing peptide receptor: a promising new biomarker to identify cervical precursor lesions and cancer.
    Rev Bras Ginecol Obstet. 2025;47:e-rbgo4.
    PubMed         Abstract available


    Sci Prog

  78. SASIVIMOLRATTANA T, Liewchalermwong S, Chantratita W, Sensorn I, et al
    Virome capture sequencing for comprehensive HPV genotyping in cervical samples.
    Sci Prog. 2025;108:368504251334515.
    PubMed         Abstract available


    Sci Rep

  79. ZHANG N, Ling H, Zhang W, Zhang M, et al
    A prediction method for radiation proctitis based on SAM-Med2D model.
    Sci Rep. 2025;15:13426.
    PubMed         Abstract available

  80. DOMINIK P, Sonja MK, Robert J, Marcin P, et al
    Effect of vaccination against HPV in the HPV-positive patients not covered by primary prevention on the disappearance of infection.
    Sci Rep. 2025;15:12642.
    PubMed         Abstract available

  81. LI C, Ke P
    Regional differences in the disease burden and attributable risk factors of female cancers.
    Sci Rep. 2025;15:13092.
    PubMed         Abstract available

  82. CHAUHAN NK, Singh K, Kumar A, Mishra A, et al
    A hybrid learning network with progressive resizing and PCA for diagnosis of cervical cancer on WSI slides.
    Sci Rep. 2025;15:12801.
    PubMed         Abstract available


    Semin Reprod Med

  83. SOLTANIZADEH S, Rosendahl M, Froding LP, Bjorn SF, et al
    After Radical Trachelectomy: Reproductive and Obstetrical Outcomes of Fertility-Sparing Surgery for Cervical Cancer.
    Semin Reprod Med. 2025 Apr 17. doi: 10.1055/s-0045-1808092.
    PubMed         Abstract available


    Sex Transm Infect

  84. NAICKER N, Osman F, Naidoo K, Bodley N, et al
    High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.
    Sex Transm Infect. 2025;101:187-190.
    PubMed         Abstract available


    Transl Cancer Res

  85. GAO X, Liu G, Zhao Z, Tang Y, et al
    Arsenic enhances cervical cancer cell radiosensitivity by suppressing the DNA damage repair pathway.
    Transl Cancer Res. 2025;14:2078-2094.
    PubMed         Abstract available


    Transl Oncol

  86. WANG X, Du Q, Mai Q, Zou Q, et al
    Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer.
    Transl Oncol. 2025;56:102396.
    PubMed         Abstract available


    West Afr J Med

  87. OWUYE AJ, Adefemi AK, Olumodeji AM, Adedeji MO, et al
    Comparative Study of Serum Malondialdehyde in Women with Cervical Cancer and Women with High-Risk Human Papillomavirus Infection at The Lagos State University Teaching Hospital, Lagos.
    West Afr J Med. 2024;41:1120-1128.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.